FAQ of our S-Trimer COVID-19 Vaccine Program

At present, all parts of the country have begun to vaccinate the new crown vaccine. In the face of the new crown vaccine, some problems still plague some people: if you have allergic rhinitis, can you get the new crown vaccine? Who should not get the new crown vaccine? Here comes the answer!

1. What is emergency use of vaccines?

Vaccine emergency use means that a new vaccine can be approved for a certain period of time and within a certain small range before the final test result has been obtained according to the procedures and the market has not been approved according to the modern drug registration application. Medical and anti-epidemic behaviors used in small groups.

2. Conditional listing of China's new crown vaccine, what is conditional listing?

Conditional approval for marketing refers to drugs that are used for severely life-threatening diseases that have no effective treatments, and drugs that are urgently needed in public health. The existing clinical research data has not yet met all the requirements for regular marketing registration, but the existing clinical trial data shows that the efficacy and It can predict its clinical value and approve marketing based on surrogate endpoints, intermediate clinical endpoints or early clinical trial data under the condition that applicants must fulfill certain conditions. Vaccines urgently needed in response to major public health emergencies or other vaccines recognized by the National Health Commission as urgently needed, based on the analysis data of the phase III clinical trial, may also be approved for listing with conditions if the benefits are greater than the risks.

3. Is the vaccinated new crown inactivated vaccine safe and effective for emergency use?

The current clinical trial results obtained at home and abroad comprehensively show that the safety after vaccination is good, the neutralizing antibody has a high positive conversion rate, and the safety and effectiveness have been fully verified in stages. Currently, hundreds of thousands of people in emergency use, especially those in high-risk countries, have not yet found serious adverse reactions.